ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 58 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $206,000 | -14.2% | 89,815 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $240,000 | -30.8% | 89,815 | -3.3% | 0.00% | 0.0% |
| Q2 2014 | $347,000 | -87.3% | 92,908 | -60.0% | 0.00% | -88.9% |
| Q1 2014 | $2,735,000 | +122.7% | 232,541 | +58.0% | 0.03% | +125.0% |
| Q4 2013 | $1,228,000 | +44.3% | 147,206 | +60.3% | 0.01% | +33.3% |
| Q3 2013 | $851,000 | +27.0% | 91,821 | +34.4% | 0.01% | +28.6% |
| Q2 2013 | $670,000 | – | 68,320 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,111,590 | $7,876,000 | 3.50% |
| Abingworth LLP | 603,740 | $2,234,000 | 1.04% |
| BVF INC/IL | 862,069 | $3,216,000 | 0.51% |
| SABBY MANAGEMENT, LLC | 922,562 | $3,441,000 | 0.15% |
| TFS CAPITAL LLC | 360,260 | $1,344,000 | 0.11% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 175,980 | $656,000 | 0.04% |
| Tekla Capital Management LLC | 113,100 | $422,000 | 0.04% |
| Visium Asset Management, LP | 598,443 | $2,232,000 | 0.04% |
| A.R.T. Advisors, LLC | 101,905 | $380,000 | 0.02% |
| B. Riley Wealth Management, Inc. | 6,300 | $23,000 | 0.02% |